Recent Security Class Actions
Correvio Pharma Corp. (NASDAQ: CORV)
Company Name:Correvio Pharma Corp.
Stock Symbol:NASDAQ: CORV
Class Period Start:09/05/2018
Class Period End (inclusive):12/10/2019
Filing Deadline:02/10/2020
According to the Complaint, Correvio Pharma Corp. is a specialty pharmaceutical company that engages in developing therapeutics worldwide. The Company’s portfolio of marketed brands comprise, among others,
vernakalant IV, or Brinavess, for the rapid conversion of recent onset AF to sinus rhythm.
